MMP-9 gene silencing by a quantum dot–siRNA nanoplex delivery to maintain the integrity of the blood brain barrier
- 27 May 2009
- journal article
- Published by Elsevier in Brain Research
- Vol. 1282, 142-155
- https://doi.org/10.1016/j.brainres.2009.05.047
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Knocking down barriers: advances in siRNA deliveryNature Reviews Drug Discovery, 2009
- Imaging Pancreatic Cancer Using Surface-Functionalized Quantum DotsThe Journal of Physical Chemistry B, 2007
- From the liver to the brain across the blood–brain barrierProceedings of the National Academy of Sciences, 2007
- Quantum Rod Bioconjugates as Targeted Probes for Confocal and Two-Photon Fluorescence Imaging of Cancer CellsNano Letters, 2007
- Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemiaAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Matrix metalloproteinase induction by EMMPRIN in experimental focal cerebral ischemiaEuropean Journal of Neuroscience, 2005
- A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimersBiochemical Journal, 2003
- Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problemsJournal of Molecular Endocrinology, 2002
- Synergistic upregulation of metalloproteinase‐9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF‐κBFEBS Letters, 1998
- Stimulation of collagen synthesis in fibroblast cultures by the tripeptide‐copper complex glycyl‐L‐histidyl‐L‐lysine‐Cu2+FEBS Letters, 1988